Search ⌘K
Tipsheet
An editorial reading of India’s listed companies.
Brief /Earnings / Ferro Alloys

Shyam Century Ferrous revenue drops as manufacturing operations cease

The company has fully shuttered its production facilities, reclassifying assets for sale while pivoting to investment management.


₹2,240 lakhs Annual revenue, down from ₹11,315 lakhs in the prior year.

What's new

  • Manufacturing operations ceased permanently in May 2025.
  • Annual revenue fell to ₹2,240 lakhs from ₹11,315 lakhs.
  • Net loss from discontinued operations reached ₹917 lakhs.

Why it matters

The company is no longer an industrial entity. With production stopped and assets marked for sale, the business has effectively become an investment vehicle supported by a ₹11,409 lakhs portfolio.

What we're watching

  • Updates on the sale of shuttered manufacturing assets.
  • The deployment of the remaining ₹16,375 lakhs net worth.
  • Strategic clarity on the company's long-term business model.

The full read

Shyam Century Ferrous has finalized its transition out of the steel business. Audited results for FY26 confirm that manufacturing ceased in May 2025, triggering a sharp drop in annual revenue to ₹2,240 lakhs from ₹11,315 lakhs in the prior year. Shareholders already approved the asset liquidation in February 2026, meaning the company’s manufacturing base is now officially classified as held for sale. Losses from these discontinued operations hit ₹917 lakhs for the year. This is a company in terminal transition. The focus has shifted entirely to its ₹11,409 lakhs investment portfolio, which now anchors a remaining net worth of ₹16,375 lakhs. These figures are backward-looking and follow a strategy already communicated to the market. There are no surprises here, only the formal conclusion of the company's industrial era.

Mentioned: Shyam Century Ferrous
Primary source BSE filings for SHYAMCENT NSE filings for SHYAMCENT Research SHYAMCENT on Tijori Finance Our reading is derived from the exchange filing. Verify on the exchange before acting.